JPMorgan Chase & Co. Purchases 396,858 Shares of Intellia Therapeutics, Inc. $NTLA
JPMorgan Chase & Co. grew its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA - Free Report) by 73.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the...